A detailed history of Huntington National Bank transactions in Organon & Co. stock. As of the latest transaction made, Huntington National Bank holds 5,283 shares of OGN stock, worth $101,327. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,283
Previous 5,602 5.69%
Holding current value
$101,327
Previous $105,000 3.81%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$17.45 - $21.96 $5,566 - $7,005
-319 Reduced 5.69%
5,283 $109,000
Q1 2024

May 03, 2024

BUY
$13.78 - $18.8 $19,195 - $26,188
1,393 Added 33.1%
5,602 $105,000
Q4 2023

Feb 07, 2024

BUY
$10.95 - $17.32 $9,241 - $14,618
844 Added 25.08%
4,209 $60,000
Q3 2023

Nov 08, 2023

SELL
$16.59 - $23.77 $7,299 - $10,458
-440 Reduced 11.56%
3,365 $58,000
Q2 2023

Aug 11, 2023

SELL
$19.27 - $24.63 $19,905 - $25,442
-1,033 Reduced 21.35%
3,805 $79,000
Q1 2023

May 10, 2023

SELL
$21.42 - $32.08 $11,288 - $16,906
-527 Reduced 9.82%
4,838 $113,000
Q4 2022

Feb 09, 2023

SELL
$23.31 - $28.61 $37,855 - $46,462
-1,624 Reduced 23.24%
5,365 $149,000
Q3 2022

Nov 07, 2022

SELL
$23.4 - $34.25 $37,393 - $54,731
-1,598 Reduced 18.61%
6,989 $163,000
Q2 2022

Aug 09, 2022

SELL
$31.66 - $38.9 $60,723 - $74,610
-1,918 Reduced 18.26%
8,587 $290,000
Q1 2022

May 10, 2022

SELL
$30.45 - $39.36 $93,420 - $120,756
-3,068 Reduced 22.6%
10,505 $367,000
Q4 2021

Jan 21, 2022

SELL
$28.67 - $37.13 $56,737 - $73,480
-1,979 Reduced 12.73%
13,573 $413,000
Q3 2021

Oct 28, 2021

BUY
$28.63 - $35.64 $250,197 - $311,457
8,739 Added 128.27%
15,552 $510,000
Q2 2021

Jul 30, 2021

BUY
$28.45 - $38.0 $193,829 - $258,894
6,813 New
6,813 $206,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.88B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.